The Implantable Artificial Heart Project
ABIOMED, Inc.
News
Press Conferences
News Releases
Frequently Asked Questions (FAQ)
Images and Diagrams
The AbioCor Replacement Heart
Frequently Asked Questions (FAQ)
Images and Diagrams
The Researchers
Laman A. Gray, Jr., M.D.
Robert D. Dowling, M.D.

Latest News

September 5, 2006

Abiomed Receives FDA Approval of The AbioCor®, The World’s First Completely Self-Contained, Implantable Artificial Heart AbioCor Granted Humanitarian Device Exemption

Louisville, KY, September 5, 2006 -- Abiomed, Inc. announced today it has received Humanitarian Device Exemption (HDE) approval from the U.S. Food and Drug Administration (FDA) for its AbioCor® Implantable Replacement Heart (AbioCor). Jewish Hospital will again be among the first U.S. hospitals to offer patients the AbioCor totally implantable replacement heart.  The Jewish Hospital/University of Louisville team principal investigators and surgeons are Laman Gray, M.D., Rob Dowling, M.D., and Sanjeev Aggarwal, M.D.

Read More

The Patient

Image of Robert L. Tools

Robert L. Tools
Born July 31, 1942
Read More

 


© 2004 Jewish Hospital, University of Louisville Health Sciences Center, ABIOMED, Inc.
Jewish Hospital University of Louisville Health Sciences Center